The Lansing State Journal reports that two of the three major research universities in the state, the University of Michigan and Wayne State University, are planning to expand their stem cell research programs in the wake of the passage of Proposal 2 earlier this month. Michigan State University is proceeding more slowly, forming an advisory committee to study the legal and ethical questions.
Proposal 2 legalized the development of new stem cell lines in the state of Michigan. Those new lines can be derived only from leftover blastocysts from fertility clinics and only with the permission of the egg and sperm donors. Researchers says they are receiving calls from fertility patients with excess blastocysts in cryogenic storage they want to donate for scientific study:
“The day after the election, the university started getting phone calls from patients who wanted to donate embryos that could no longer be used,” said Sean Morrison, director of U of M’s Center for Stem Cell Biology.
The university isn’t accepting such donations yet. Internal oversight groups still need to approve the first round of research proposals, Morrison said.
But he expected that such approvals would be done before spring and was optimistic about the progress that would follow.
During in vitro fertilization fertility treatments, doctors will fertilize as many eggs as can be harvested from the female. They then typically choose the strongest one or two to implant, while the rest are frozen for future use. If pregnancy is successful, those frozen embryos can either be used for scientific research or they will end up being discarded.